Collaboration between the U.S. R&D Base and Medical Institutions and External Partners
First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2019.
13 other companies' latest entry also says "Restated".
- FY2019RestatedAnnual report
「As part of the globalization of our R&D structure, at consolidated subsidiary ASAHI INTECC USA, INC., the base for direct sales in the United States, we have established an R&D structure capable of responding through the prototype stage, allowing us to directly incorporate the needs and evaluations of physicians, our end customers. We are also further expanding the R&D base of consolidated subsidiary ASAHI INTECC THAILAND CO., LTD. and will pursue improvements to existing products, including reviewing product specifications, more proactively.」
The company continues to maintain a prototyping structure in the United States that reflects physicians’ needs, as well as its policy of expanding the R&D base in Thailand. - FY2018RestatedAnnual report
「At consolidated subsidiary ASAHI INTECC USA, INC., the base for direct sales in the United States, we have established an R&D structure capable of responding through the prototype stage, allowing us to directly incorporate the needs and evaluations of physicians, our end customers. We are also further expanding the R&D base of consolidated subsidiary ASAHI INTECC THAILAND CO., LTD. and will pursue improvements to existing products, including reviewing product specifications, more proactively.」
The company continues to maintain a prototyping structure in the United States that reflects physicians’ needs, as well as its policy of expanding the R&D base in Thailand. - FY2017RestatedAnnual report
「In recent years, we have also strengthened our joint R&D system with leading physicians in each field who have extensive experience in clinical settings, leveraging the functions unique to our company, and have been developing products closely aligned with frontline medical needs.」
The company continues to operate a global R&D system, including its U.S. R&D center, and conduct joint research with leading physicians. - FY2016First statedAnnual report
「In addition, we established a new R&D center at ASAHI INTECC USA, INC., our consolidated U.S. sales subsidiary, enabling us to produce prototypes and directly reflect the needs and evaluations of leading physicians working close to the front lines of medical care. By globalizing our R&D system, including prototype development, we will strengthen our capabilities in the field.」
The company says it will establish an R&D center in the United States capable of producing prototypes and will also leverage joint research with leading physicians, technology partnerships and M&A.